acrolein has been researched along with n-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basak, R; Borgas, D; Chambers, E; Choudhary, G; Lange, T; Lu, Q; Mundy, M; Newton, J; Oldham, M; Rounds, S; Yao, H | 1 |
| Chen, Y; Fan, X; Liu, W; Wang, J; Wang, W; Zhai, X; Zhang, Z; Zheng, B | 1 |
2 other study(ies) available for acrolein and n-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide
| Article | Year |
|---|---|
Alda-1 Protects Against Acrolein-Induced Acute Lung Injury and Endothelial Barrier Dysfunction.
Topics: Acetylcysteine; Acrolein; Acute Lung Injury; AMP-Activated Protein Kinases; Animals; Benzamides; Benzodioxoles; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Male; Mice; Mitochondria; Oxygen Consumption | 2017 |
Aldehyde dehydrogenase 2 activation ameliorates cyclophosphamide-induced acute cardiotoxicity via detoxification of toxic aldehydes and suppression of cardiac cell death.
Topics: Acrolein; Aldehyde Dehydrogenase, Mitochondrial; Aldehydes; Animals; Apoptosis; Benzamides; Benzodioxoles; Cardiotoxicity; Cell Death; Cyclophosphamide; Humans; Inactivation, Metabolic; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Reactive Oxygen Species | 2018 |